Fractional Exhaled Nitric Oxide (FeNO) Integrating Airway Hyperresponsiveness (AHR) Examination Promotes Etiologic Diagnosis and Treatment for Children with Chronic Cough

Haiyan Zhu; Chuangli Hao; Xingmei Yu; Rongrong Zhang; Wendi Zhou; Xingzhen Sun; Yufang Yuan; Zhaofang Tian

doi:10.12659/MSM.928502

22 February 2021: Clinical Research

Fractional Exhaled Nitric Oxide (FeNO) Integrating Airway Hyperresponsiveness (AHR) Examination Promotes Etiologic Diagnosis and Treatment for Children with Chronic Cough

Haiyan Zhu ^1BCDEF , Chuangli Hao ^2BCDE , Xingmei Yu ^2BCDF , Rongrong Zhang ^1BCD , Wendi Zhou ^1BCF , Xingzhen Sun ^1BCF , Yufang Yuan ^1BCF , Zhaofang Tian ^1ABDEG*

DOI: 10.12659/MSM.928502

Med Sci Monit 2021; 27:e928502

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

View HTML version

Figure 1 Linear correlation analysis for the correlation between fractional exhaled nitric oxide (FeNO) levels and eosinophils (EOS) in sputum (A) or cough symptom scores (B).

Back to the Article

Fractional Exhaled Nitric Oxide (FeNO) Integrating Airway Hyperresponsiveness (AHR) Examination Promotes Etiologic Diagnosis and Treatment for Children with Chronic Cough

Your Privacy